Benefits of long-acting β2-agonists -: Reply

被引:0
|
作者
Gibson, Peter G. [1 ]
Ducharme, Francine M.
Cates, Christopher Joseph
机构
[1] John Hunter Hosp, Newcastle, NSW, Australia
[2] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Montreal, PQ, Canada
[3] St Georges Univ London, London, England
关键词
D O I
10.1016/j.jaci.2007.04.043
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:726 / 726
页数:1
相关论文
共 50 条
  • [41] Are long acting β2-agonists safe?
    Gillissen, Adrian
    MEDIZINISCHE KLINIK, 2009, 104 (11) : 885 - 886
  • [42] Inhaled corticosteroids plus long-acting β2-agonists as a combined therapy in asthma
    García-Marcos, L
    Schuster, A
    Barroso, NC
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (01) : 23 - 39
  • [43] Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroids
    Barnes, PJ
    EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (01) : 182 - 191
  • [44] Long-Acting β2-Agonists During Pregnancy And Risk Of Hypertensive Disorders Of Pregnancy
    Blais, L.
    Kettani, F. -Z.
    Forget, A.
    Beauchesne, M. -F.
    Lemiere, C.
    Rey, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [45] Inhaled combination therapy with long-acting β2-agonists and corticosteroids in stable COPD
    Cazzola, M
    Dahl, R
    CHEST, 2004, 126 (01) : 220 - 237
  • [46] Long-Acting β2-Agonists and Risk of Hypertensive Disorders of Pregnancy: A Cohort Study
    Blais, Lucie
    Kettani, Fatima-Zohra
    Forget, Amelie
    Beauchesne, Marie-France
    Lemiere, Catherine
    Rey, Evelyne
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (02): : 555 - +
  • [47] Long-acting β2-agonists in management of childhood asthma:: A critical review of the literature
    Bisgaard, H
    PEDIATRIC PULMONOLOGY, 2000, 29 (03) : 221 - 234
  • [48] The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPD
    Cazzola, Mario
    Molimard, Mathieu
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2010, 23 (04) : 257 - 267
  • [49] Characteristics of users of inhaled long-acting β2-agonists in a Southern European population
    Castellsague, J
    Garcia-Rodríguez, LA
    Pérez-Gutthann, S
    Agostinis, L
    Cattaruzi, C
    Troncon, MG
    RESPIRATORY MEDICINE, 1999, 93 (10) : 709 - 714
  • [50] Reduce use of long-acting β2-agonists in asthma therapy, FDA says
    Thompson, Cheryl A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (07) : 504 - +